Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
StepStone Group
STEP
$3.97B
| $1.91M | ﹤0.01% |
48,080
-410,340
| -90% | -$11.9M |
|
5302
Associated Banc-Corp
ASB
$6.11B
| $1.91M | ﹤0.01% |
112,039
-722,535
| -87% | -$11M |
|
|
ESPR
5303
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.91M | ﹤0.01% |
73,500
+48,400
| +193% | +$1.45M |
|
5304
CALL
Red Robin
RRGB
$200M
| $1.91M | ﹤0.01% |
99,400
+8,400
| +9% | +$141K |
|
|
CHNG
5305
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $1.91M | ﹤0.01% |
102,400
+18,000
| +21% | +$296K |
|
5306
iShares Global REIT ETF
REET
$5.06B
| $1.91M | ﹤0.01% |
79,746
-142,435
| -64% | -$3.21M |
|
|
ZYXI
5307
DELISTED
Zynex
ZYXI
| $1.91M | ﹤0.01% |
155,850
+25,092
| +19% | +$326K |
|
5308
PUT
United Microelectronic
UMC
$49B
| $1.9M | ﹤0.01% |
225,900
+194,100
| +610% | +$1.27M |
|
5309
CALL
Brookfield
BN
$105B
| $1.9M | ﹤0.01% |
86,137
+10,650
| +14% | +$213K |
|
5310
PUT
Laureate Education
LAUR
$5.18B
| $1.9M | ﹤0.01% |
130,600
+55,100
| +73% | +$778K |
|
|
GTHX
5311
PUT
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.9M | ﹤0.01% |
105,700
+8,800
| +9% | +$131K |
|
5312
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $1.9M | ﹤0.01% |
+13,365
| New | +$1.72M |
|
5313
First Citizens BancShares
FCNCA
$25.4B
| $1.9M | ﹤0.01% |
3,309
-4,506
| -58% | -$2.27M |
|
5314
PUT
Charles River Laboratories
CRL
$13.7B
| $1.9M | ﹤0.01% |
7,600
-1,500
| -16% | -$357K |
|
5315
PUT
Precigen
PGEN
$2.35B
| $1.9M | ﹤0.01% |
186,100
+102,400
| +122% | +$664K |
|
5316
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
| $1.9M | ﹤0.01% |
42,361
-100,300
| -70% | -$4.14M |
|
5317
Innovator US Equity Buffer ETF June
BJUN
$322M
| $1.9M | ﹤0.01% |
60,812
+1,065
| +2% | +$32.4K |
|
|
5318
United Microelectronic
UMC
$49B
| $1.9M | ﹤0.01% |
224,968
-109,661
| -33% | -$715K |
|
5319
State Street SPDR S&P Global Dividend ETF
WDIV
$289M
| $1.9M | ﹤0.01% |
31,420
-19,207
| -38% | -$1.11M |
|
|
TSC
5320
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.9M | ﹤0.01% |
109,011
+2,891
| +3% | +$43.5K |
|
5321
PUT
Momentus
MNTS
$88.3M
| $1.9M | ﹤0.01% |
+8
| New | +$1.26M |
|
5322
AeroVironment
AVAV
$9.17B
| $1.89M | ﹤0.01% |
21,787
-54,481
| -71% | -$4.37M |
|
5323
PUT
Westlake Corp
WLK
$10.2B
| $1.89M | ﹤0.01% |
23,200
-6,600
| -22% | -$493K |
|
5324
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$206M
| $1.89M | ﹤0.01% |
1,720
-920
| -35% | -$1.22M |
|
5325
Energizer
ENR
$1.56B
| $1.89M | ﹤0.01% |
44,733
+30,288
| +210% | +$1.28M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.